FILANA THERAPEUTICS, INC. (FLNA) › Capital ExpendituresFILANA THERAPEUTICS, INC. (FLNA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $80.0K2015: $195.0K2016: $75.0K2019: $18.0K2021: $22.21M2022: $2.71M2023: $414.0K2024: $103.0K2025: $581.0K$581.0K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$581.0K+464.1%2024$103.0K-75.1%2023$414.0K-84.7%2022$2.71M-87.8%2021$22.21M—2019$18.0K—2016$75.0K-61.5%2015$195.0K+143.8%2014$80.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share